Model
Edge
Ultragenyx Pharmaceutical Inc.
0001603347
Filing type
4
Filing date
Apr 23, 2026
Updated
Apr 24, 2026 ยท 2:39 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership